Literature DB >> 16415376

Common sodium channel promoter haplotype in asian subjects underlies variability in cardiac conduction.

Connie R Bezzina1, Wataru Shimizu, Ping Yang, Tamara T Koopmann, Michael W T Tanck, Yoshihiro Miyamoto, Shiro Kamakura, Dan M Roden, Arthur A M Wilde.   

Abstract

BACKGROUND: Reduced cardiac sodium current slows conduction and renders the heart susceptible to ventricular fibrillation. Loss of function mutations in SCN5A, encoding the cardiac sodium channel, are one cause of the Brugada syndrome, associated with slow conduction and a high incidence of ventricular fibrillation, especially in Asians. In this study, we tested the hypothesis that an SCN5A promoter polymorphism common in Asians modulates variability in cardiac conduction. METHODS AND
RESULTS: Resequencing 2.8 kb of SCN5A promoter identified a haplotype variant consisting of 6 polymorphisms in near-complete linkage disequilibrium that occurred at an allele frequency of 22% in Asian subjects and was absent in whites and blacks. Reporter activity of this variant haplotype, designated HapB, in cardiomyocytes was reduced 62% compared with wild-type haplotype (P=0.006). The relationship between SCN5A promoter haplotype and PR and QRS durations, indexes of conduction velocity, was then analyzed in a cohort of 71 Japanese Brugada syndrome subjects without SCN5A mutations and in 102 Japanese control subjects. In both groups, PR and QRS durations were significantly longer in HapB individuals (P< or =0.002) with a gene-dose effect. In addition, up to 28% and 48% of variability in PR and QRS durations, respectively, were attributable to this haplotype. The extent of QRS widening during challenge with sodium channel blockers, known to be arrhythmogenic in Brugada syndrome and other settings, was also genotype dependent (P=0.002).
CONCLUSIONS: These data demonstrate that genetically determined variable sodium channel transcription occurs in the human heart and is associated with variable conduction velocity, an important contributor to arrhythmia susceptibility.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16415376     DOI: 10.1161/CIRCULATIONAHA.105.580811

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  60 in total

1.  Pharmacology and Toxicology of Nav1.5-Class 1 anti-arrhythmic drugs.

Authors:  Dan M Roden
Journal:  Card Electrophysiol Clin       Date:  2014-12-01

Review 2.  Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights.

Authors:  Jelena Kornej; Christin S Börschel; Emelia J Benjamin; Renate B Schnabel
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

3.  Genetic basis of Brugada syndrome.

Authors:  Charles Antzelevitch
Journal:  Heart Rhythm       Date:  2007-03-23       Impact factor: 6.343

Review 4.  Drug-induced spatial dispersion of repolarization.

Authors:  Charles Antzelevitch
Journal:  Cardiol J       Date:  2008       Impact factor: 2.737

Review 5.  Genetic testing for inherited cardiac disease.

Authors:  Arthur A M Wilde; Elijah R Behr
Journal:  Nat Rev Cardiol       Date:  2013-07-30       Impact factor: 32.419

6.  Brugada-type electrocardiogram in a patient with hypothyroidism.

Authors:  Kayano Taira; Akihisa Fujino; Tatsuya Watanabe; Atsuhiro Ogyu; Kouichi Ashikawa; Wataru Shimizu
Journal:  J Cardiol Cases       Date:  2010-07-06

7.  Evolution of ventricular myocyte electrophysiology.

Authors:  Barbara Rosati; Min Dong; Lan Cheng; Shian-Ren Liou; Qinghong Yan; Ji Young Park; Elaine Shiang; Michael Sanguinetti; Hong-Sheng Wang; David McKinnon
Journal:  Physiol Genomics       Date:  2008-09-02       Impact factor: 3.107

8.  Subepicardial phase 0 block and discontinuous transmural conduction underlie right precordial ST-segment elevation by a SCN5A loss-of-function mutation.

Authors:  Markéta Bébarová; Tom O'Hara; Jan L M C Geelen; Roselie J Jongbloed; Carl Timmermans; Yvonne H Arens; Luz-Maria Rodriguez; Yoram Rudy; Paul G A Volders
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-02       Impact factor: 4.733

9.  Genetics can contribute to the prognosis of Brugada syndrome: a pilot model for risk stratification.

Authors:  Elena Sommariva; Carlo Pappone; Filippo Martinelli Boneschi; Chiara Di Resta; Maria Rosaria Carbone; Erika Salvi; Pasquale Vergara; Simone Sala; Daniele Cusi; Maurizio Ferrari; Sara Benedetti
Journal:  Eur J Hum Genet       Date:  2013-01-16       Impact factor: 4.246

10.  SCN5A allelic expression imbalance in African-Americans heterozygous for the common variant p.Ser1103Tyr.

Authors:  Stacy A S Killen; Jennifer Kunic; Lily Wang; Adele Lewis; Bruce P Levy; Michael J Ackerman; Alfred L George
Journal:  BMC Med Genet       Date:  2010-05-14       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.